# Efficacy of New Trio Combination for Melasma

> **NCT07676994** · PHASE4 · COMPLETED · sponsor: **Ghurki Trust and Teaching Hospital** · enrollment: 56 (actual)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** New trio combination
- **DRUG:** Kligman's formula (trio)

## Key facts

- **NCT ID:** NCT07676994
- **Lead sponsor:** Ghurki Trust and Teaching Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-07
- **Primary completion:** 2025-12-07
- **Final completion:** 2026-01-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07676994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07676994, "Efficacy of New Trio Combination for Melasma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07676994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*